Esperion Therapeutics (ESPR) Change in Inventory (2020 - 2026)

Esperion Therapeutics has reported Change in Inventory for 7 years, with the latest figure at -$915000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 118.94% year-over-year to -$915000.0; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 81.37% YoY), and the FY2025 full-year result was $10.6 million, down 63.17% from the prior year.
• Change in Inventory for Q1 2026 stood at -$915000.0, up from -$3.4 million in the prior quarter.
• The five-year high for Change in Inventory was $15.1 million in Q2 2025, with the low at -$6.4 million in Q2 2022.
• Historically, Change in Inventory has averaged $4.1 million across 5 years, with a median of $4.8 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Inventory slumped 274.32% — and 2023, when it jumped 1739.94%.
• Esperion Therapeutics' Change in Inventory stood at $5.7 million in 2022, then soared by 150.85% to $14.2 million in 2023, then gained by 1.42% to $14.4 million in 2024, then slumped by 123.73% to -$3.4 million in 2025, then surged by 73.21% to -$915000.0 in 2026.
• The last three Change in Inventory figures came in at -$915000.0 (Q1 2026), -$3.4 million (Q4 2025), and -$5.9 million (Q3 2025), per Business Quant data.